FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3034851528> ?p ?o ?g. }

• W3034851528 endingPage "722" @default.
• W3034851528 startingPage "715" @default.
• W3034851528 abstract "Use of high-risk medications is common and associated with adverse effects in older adults, including those living with dementia. A Computerised Clinical Decision Support System (CCDSS) called G-MEDSS© (Goal-directed Medication Review Electronic Decision Support System) contains tools that identify medications with anticholinergic and sedative effects and align older adult's health and medication goals of care with medication management strategies. To describe the utility of a CCDSS called G-MEDSS in Home Medicines Review (HMR) by an accredited clinical pharmacist (ACP) using a mixed-methods process evaluation method. A mixed-methods process evaluation was conducted as part of a nation-wide cluster-randomised clinical trial evaluating the effectiveness of implementing G-MEDSS in HMR. Data were collected from ACPs and HMR recipients (the patient) using a feedback survey (ACPs and HMR recipients) and one-on-one telephone interviews (HMR recipients). Quantitative and qualitative data were combined at the start of analysis. Content analysis of the qualitative data was conducted, and emerging categories were linked to quantitative data. Feedback surveys were completed by eight ACPs and 26 HMR recipients; 11 HMR recipients completed one-on-one telephone interviews. Overall, ACPs and HMR recipients who received the intervention reported a positive attitude towards the utility of G-MEDSS in HMR. ACPs reported that G-MEDSS enhanced their ability to make evidence-based recommendations about anticholinergic and sedative medications, and to better align HMR recommendations with HMR recipients’ goals of care. However, ACPs described that it was difficult to obtain goals of care from HMR recipients. HMR recipients gave mixed reports about the ACPs consultations: some HMR recipients reported that they were engaged in discussions about their views on medications, whilst other participants reported that discussions about their concerns towards medications and goals was limited. This study suggests that a CCDSS, such as G-MEDSS, demonstrates good utility to assist ACPs to identify and assess anticholinergic and sedative medications. Given the mixed feedback from the ACPs on the different components of the G-MEDSS, further refinement of these tools and their use in combination in practice may be needed." @default.
• W3034851528 created "2020-06-19" @default.
• W3034851528 creator A5000191861 @default.
• W3034851528 creator A5003060830 @default.
• W3034851528 creator A5005856537 @default.
• W3034851528 creator A5008298503 @default.
• W3034851528 creator A5015790069 @default.
• W3034851528 creator A5053547123 @default.
• W3034851528 creator A5053574319 @default.
• W3034851528 creator A5063428081 @default.
• W3034851528 date "2021-04-01" @default.
• W3034851528 modified "2023-10-14" @default.
• W3034851528 title "The utility of a computerised clinical decision support system intervention in home medicines review: A mixed-methods process evaluation" @default.
• W3034851528 cites W1896439441 @default.
• W3034851528 cites W1968911438 @default.
• W3034851528 cites W1990480169 @default.
• W3034851528 cites W1991833417 @default.
• W3034851528 cites W2004828581 @default.
• W3034851528 cites W2014927723 @default.
• W3034851528 cites W2043224889 @default.
• W3034851528 cites W2081315480 @default.
• W3034851528 cites W2094290366 @default.
• W3034851528 cites W2126292472 @default.
• W3034851528 cites W2128920447 @default.
• W3034851528 cites W2131914658 @default.
• W3034851528 cites W2134615004 @default.
• W3034851528 cites W2142275623 @default.
• W3034851528 cites W2161846888 @default.
• W3034851528 cites W2165057233 @default.
• W3034851528 cites W2168053015 @default.
• W3034851528 cites W2199386711 @default.
• W3034851528 cites W2225501799 @default.
• W3034851528 cites W2278219809 @default.
• W3034851528 cites W2295734069 @default.
• W3034851528 cites W2330995426 @default.
• W3034851528 cites W2340507627 @default.
• W3034851528 cites W2412800873 @default.
• W3034851528 cites W2417720564 @default.
• W3034851528 cites W2545226230 @default.
• W3034851528 cites W2769461077 @default.
• W3034851528 cites W2789484076 @default.
• W3034851528 cites W2885908504 @default.
• W3034851528 cites W2893710135 @default.
• W3034851528 cites W2897676853 @default.
• W3034851528 cites W3008444487 @default.
• W3034851528 doi "https://doi.org/10.1016/j.sapharm.2020.06.010" @default.
• W3034851528 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32788083" @default.
• W3034851528 hasPublicationYear "2021" @default.
• W3034851528 type Work @default.
• W3034851528 sameAs 3034851528 @default.
• W3034851528 citedByCount "12" @default.
• W3034851528 countsByYear W30348515282020 @default.
• W3034851528 countsByYear W30348515282021 @default.
• W3034851528 countsByYear W30348515282022 @default.
• W3034851528 countsByYear W30348515282023 @default.
• W3034851528 crossrefType "journal-article" @default.
• W3034851528 hasAuthorship W3034851528A5000191861 @default.
• W3034851528 hasAuthorship W3034851528A5003060830 @default.
• W3034851528 hasAuthorship W3034851528A5005856537 @default.
• W3034851528 hasAuthorship W3034851528A5008298503 @default.
• W3034851528 hasAuthorship W3034851528A5015790069 @default.
• W3034851528 hasAuthorship W3034851528A5053547123 @default.
• W3034851528 hasAuthorship W3034851528A5053574319 @default.
• W3034851528 hasAuthorship W3034851528A5063428081 @default.
• W3034851528 hasConcept C104863432 @default.
• W3034851528 hasConcept C119857082 @default.
• W3034851528 hasConcept C159110408 @default.
• W3034851528 hasConcept C177713679 @default.
• W3034851528 hasConcept C2776484012 @default.
• W3034851528 hasConcept C2779457091 @default.
• W3034851528 hasConcept C2780665704 @default.
• W3034851528 hasConcept C36434225 @default.
• W3034851528 hasConcept C41008148 @default.
• W3034851528 hasConcept C509550671 @default.
• W3034851528 hasConcept C512399662 @default.
• W3034851528 hasConcept C61521584 @default.
• W3034851528 hasConcept C71924100 @default.
• W3034851528 hasConcept C87156501 @default.
• W3034851528 hasConceptScore W3034851528C104863432 @default.
• W3034851528 hasConceptScore W3034851528C119857082 @default.
• W3034851528 hasConceptScore W3034851528C159110408 @default.
• W3034851528 hasConceptScore W3034851528C177713679 @default.
• W3034851528 hasConceptScore W3034851528C2776484012 @default.
• W3034851528 hasConceptScore W3034851528C2779457091 @default.
• W3034851528 hasConceptScore W3034851528C2780665704 @default.
• W3034851528 hasConceptScore W3034851528C36434225 @default.
• W3034851528 hasConceptScore W3034851528C41008148 @default.
• W3034851528 hasConceptScore W3034851528C509550671 @default.
• W3034851528 hasConceptScore W3034851528C512399662 @default.
• W3034851528 hasConceptScore W3034851528C61521584 @default.
• W3034851528 hasConceptScore W3034851528C71924100 @default.
• W3034851528 hasConceptScore W3034851528C87156501 @default.
• W3034851528 hasFunder F4320320433 @default.
• W3034851528 hasFunder F4320320555 @default.
• W3034851528 hasFunder F4320320966 @default.
• W3034851528 hasFunder F4320334704 @default.
• W3034851528 hasFunder F4320334705 @default.
• W3034851528 hasIssue "4" @default.

• next